SandyFengMD

General Surgery • San Francisco, CA

Transplantation

Professor, Surgery, UCSF School of Medicine

Join to view full profile

Dr. Feng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Feng's full profile

Already have an account?

Office
400 Parnassus Ave
San Francisco, CA 94143
Phone+1 415-353-2318

Fax+1 415-353-8917

Education & Training

Brigham and Women's HospitalResidency, Surgery, 1990 - 1995
Stanford University School of MedicineClass of 1990

Certifications & Licensure

CA State Medical License 1996 - 2025
MA State Medical License 1991 - 2002
American Board of Surgery Surgery

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com

Clinical Trials

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients Start of enrollment: 2006 Jun 05
Completed
Phase 1
Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients Start of enrollment: 2011 Oct 01
Completed
Phase 2
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation Start of enrollment: 2014 Dec 17
Terminated
Phase 1
Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction Start of enrollment: 2016 Jun 06
Completed
Phase 1, Phase 2
Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation Start of enrollment: 2015 Dec 15
Completed
Phase 2
A Cohort Study of Operationally Tolerant Allograft Recipients Start of enrollment: 2016 Jun 30
Terminated
Liver Transplantation With Tregs at UCSF Start of enrollment: 2021 Apr 22
Terminated
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Defining an NK Cell-enriched Rejection-like Phenotype in Liver Transplant Biopsies From the INTERLIVER Study.
Katelynn S Madill-Thomsen, Patrick T Gauthier, Marwan Abouljoud, Chandra Bhati, David Bruno
Transplantation. 2025-01-09
Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter coh...
Naoki Tanimine, James F Markmann, Michelle A Wood-Trageser, Anthony J Demetris, Kristen Mason
American Journal of Transplantation. 2024-11-04
1 citations
The type, duration, and severity of pretransplant kidney injury predict prolonged kidney dysfunction after liver transplantation.
Wesley Dixon, Sandy Feng, Garrett R Roll, Mehdi Tavakol, Cynthia Fenton
Liver Transplantation. 2024-11-01

Journal Articles

Prevalence and Impact of De Novo DSA During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients
Sandy Feng, Josh Levitsky, Peter Sayre, Matthew J Everly, Abraham Shaked, Hepatology
Instituting an Immune Tolerance Program: Hidden Challenges and Opportunities. Reply: Tolerance After Liver Transplantation: How to Implement a Program of Immune Tolera...
Sandy Feng, MD, Liver transplantation
Liver Transplants for Non‐citizens/non‐Residents: What Is the Problem and What Should Be Done?
Sandy Feng, MD, American journal of transplantation
Tolerance After Liver Transplantation: Where Are We?
Sandy Feng, MD, Liver transplantation
Join now to see all

Press Mentions

FDA Panel Supports Islet Cell Treatment for Type 1 DiabetesApril 16th, 2021
Pure Red Cell Aplasia After Kidney TransplantationMay 28th, 2019
Pericardial Effusion with Necrotic Ventricular Mass in a Kidney Transplant RecipientApril 24th, 2019
Join now to see all